IHS Chemical Week

People & Business :: M&A

Daiichi Closes Ranbaxy Deal for $4.15 Billion

9:29 AM MST | November 18, 2008 | Deepti Ramesh

Daiichi Sankyo (Tokyo) says it has completed the acquisition of a majority stake in India’s largest pharmaceutical company, Ranbaxy Laboratories (Gurgaon, India), with the final transfer of the remaining equity shares of Ranbaxy’s founders, the Singh family. Daiichi Sankyo now holds 63.92% of Ranbaxy and paid a total of about $4.15 billion for the stake. Malvinder Singh, head of Ranbaxy, shakes on the deal with Takashi Shoda, head of Daiichi Sankyo. Daiichi Sankyo signed a deal with Ranbaxy last June to acquire the shares from the Singh family and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa